SEC Form NT 10-Q filed by OneMedNet Corp
SEC File Number: 001-40386
CUSIP Number:
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
| (Check One): | ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q |
| ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR |
For period ended: September 30, 2024
| ☐ | Transition Report on Form 10-K |
| ☐ | Transition Report on Form 20-F |
| ☐ | Transition Report on Form 11-K |
| ☐ | Transition Report on Form 10-Q |
| ☐ | Transition Report on Form N-SAR |
For the transition period ended: ________________________________________________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: ____________________________________________________________________________________
Part I. Registrant Information
| Full Name of Registrant: | OneMedNet Corporation |
| Former Name if Applicable: | Data Knights Acquisition Corp. |
| Address of Principal Executive Office (Street and Number): | 6385 Old Shady Oak Road, Suite 250 |
| City, State and Zip Code: | Eden Prairie, MN 55344 |
Part II. Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
| (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; | ||
| ☒ | (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and | |
| (c)The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
Part III. Narrative
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
OneMedNet Corporation (the “Company”) has determined that it is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the three months ended September 30, 2024 (the “Form 10-Q”) by the prescribed due date, as the Company requires additional time to gather necessary information for the preparation of such Form 10-Q, and additional time for corresponding review by the Company’s independent registered public accounting firm of the Form 10-Q.
Part IV. Other Information
(1) Name and telephone number of person to contact in regard to this notification
| Aaron Green | (800) | 918-7189 | ||
| (name) | (area code) | (telephone number) |
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
☐ Yes ☒ No
Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 and June 30, 2024.
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
☒ Yes ☐ No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
The Company’s results of operations for the quarter ended September 30, 2024 will be significantly different from the results of operations from the corresponding period in the prior fiscal year due primarily to the consummation of the Company’s business combination with OneMedNetSolutions Corporation on November 7, 2023. A reasonable estimate of such results could not be made until the completion of the open audit and technical accounting matters referenced in Part III.
| OneMedNet Corporation |
| (Name of Registrant as Specified in Charter) |
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
| Date | November 15, 2024 | By | /s/ Aaron Green | |
Aaron Green Chief Executive Officer (Principal Executive Officer) |
Instruction. The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).